Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma

Aims Deleted in liver cancer 1 (DLC1), a member of RhoGTPase activating protein (GAP) family, is known to have suppressive activities in tumorigenicity and cancer metastasis. However, the underlying molecular mechanisms of how DLC1 suppresses cell motility have not been fully elucidated. Rho-kinase (ROCK) is an immediate down-stream effector of RhoA in mediating cellular cytoskeletal events and cell motility. In the present study, we aimed to investigate the effects of DLC1 on Rho/ROCK signaling pathway in hepatocellular carcinoma (HCC). Methodology/Principal Findings We demonstrated that DLC1 negatively regulated ROCK-dependent actomyosin contractility. From immumofluorescence study, we found that ectopic expression of DLC1 abrogated Rho/ROCK-mediated cytoskeletal reorganization including formation of stress fibers and focal adhesions. It also downregulated cortical phosphorylation of myosin light chain 2 (MLC2). These inhibitory events by DLC1 were RhoGAP-dependent, as RhoGAP-deficient mutant of DLC1 (DLC1 K714E) abolished these inhibitory events. In addition, from western study, DLC1 inhibited ROCK-related myosin light chain phosphatase targeting unit 1 (MYPT1) phosphorylation at Threonine 853. By examining cell morphology under microscope, we found that ectopic expression of dominant-active ROCK released cells from DLC1-induced cytoskeletal collapse and cell shrinkage. Conclusion Our data suggest that DLC1 negatively regulates Rho/ROCK/MLC2. This implicates a ROCK-mediated pathway of DLC1 in suppressing metastasis of HCC cells and enriches our understanding in the molecular mechanisms involved in the progression of hepatocellular carcinoma.

• Publication year

  2008

• Venue

  PLoS ONE

• Publication date

  2008-07-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0002779PMID 18648664PMCID 2464714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma.

  2008cited by this paper
• DLC‐1 suppresses non‐small cell lung cancer growth and invasion by RhoGAP‐dependent and independent mechanisms

  2008cited by this paper
• Actin stress fibres

  2007cited by this paper
• The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation

  2007cited by this paper
• ROCK1 Phosphorylates and Activates Zipper-interacting Protein Kinase*

  2007cited by this paper
• DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.

  2007cited by this paper
• The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1

  2007cited by this paper
• Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities

  2007cited by this paper
• The Forces Behind Cell Movement

  2007cited by this paper
• The Abl-related gene tyrosine kinase acts through p190RhoGAP to inhibit actomyosin contractility and regulate focal adhesion dynamics upon adhesion to fibronectin.

  2007cited by this paper
• Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors.

  2006cited by this paper
• Aberrant Methylation and Deacetylation of Deleted in Liver Cancer-1 Gene in Prostate Cancer: Potential Clinical Applications

  2006cited by this paper
• Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.

  2006cited by this paper
• Endosomes generate localized Rho–ROCK–MLC2–based contractile signals via Endo180 to promote adhesion disassembly

  2006cited by this paper
• [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].

  2005cited by this paper
• Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling

  2005cited by this paper
• Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.

  2005cited by this paper
• Cdc42–MRCK and Rho–ROCK signalling cooperate in myosin phosphorylation and cell invasion

  2005cited by this paper
• The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

  2005cited by this paper
• Regulation of cancer cell motility through actin reorganization

  2005cited by this paper
• Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.

  2005influential reference
• p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling

  2005cited by this paper
• Intrathecal Administration of Y-27632, a Specific Rho-Associated Kinase Inhibitor, for Rat Neoplastic Meningitis

  2005cited by this paper
• Regulation of PTEN by Rho small GTPases

  2005cited by this paper
• Characterization of a Novel GTPase-activating Protein Associated with Focal Adhesions and the Actin Cytoskeleton*

  2005influential reference
• DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas

  2004cited by this paper
• A PLCδ1-binding protein, p122RhoGAP, is localized in focal adhesions

  2004cited by this paper
• Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells

  2004cited by this paper
• A PLCdelta1-binding protein, p122RhoGAP, is localized in focal adhesions.

  2004cited by this paper
• Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.

  2003cited by this paper
• Analysis of DLC-1 expression in human breast cancer

  2003cited by this paper
• Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.

  2003cited by this paper
• DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity

  2003cited by this paper
• Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis

  2003cited by this paper
• Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

  2003influential reference
• ROCKs: multifunctional kinases in cell behaviour

  2003cited by this paper
• Rho-kinase contributes to diphosphorylation of myosin II regulatory light chain in nonmuscle cells

  2002cited by this paper
• Regulation of substrate adhesion dynamics during cell motility.

  2002cited by this paper
• Characterization of RhoA-binding Kinase ROKα Implication of the Pleckstrin Homology Domain in ROKα Function Using Region-specific Antibodies*

  2002cited by this paper
• Rho-Kinase–Mediated Contraction of Isolated Stress Fibers

  2001cited by this paper
• Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes.

  2001cited by this paper
• Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho‐associated protein kinase inhibitor Y‐27632

  2001cited by this paper
• RhoA is required for monocyte tail retraction during transendothelial migration

  2001cited by this paper
• DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.

  2000cited by this paper
• Distinct Roles of Rock (Rho-Kinase) and Mlck in Spatial Regulation of Mlc Phosphorylation for Assembly of Stress Fibers and Focal Adhesions in 3t3 Fibroblasts

  2000cited by this paper
• Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.

  2000cited by this paper
• Cell motility mediated by rho and rho‐associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma

  1999cited by this paper
• The COOH Terminus of Rho-kinase Negatively Regulates Rho-kinase Activity*

  1999cited by this paper
• Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells.

  1999cited by this paper
• An essential part for Rho–associated kinase in the transcellular invasion of tumor cells

  1999cited by this paper
• Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.

  1998cited by this paper
• Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells*

  1998cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions

  1997cited by this paper
• Rho‐associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho.

  1996cited by this paper
• Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)*

  1996cited by this paper
• The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton

  1996influential reference
• Identification of a Putative Target for Rho as the Serine-Threonine Kinase Protein Kinase N

  1996cited by this paper
• Signal transduction through small GTPases--a tale of two GAPs.

  1992cited by this paper

• Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy

  2025cites this paper
• Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?

  2023cites this paper
• Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

  2023cites this paper
• Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers

  2022cites this paper
• CDK5 inhibition promotes osteoblastic differentiation of MSCs and blocks the migration of osteosarcoma MG-63 cells

  2022cites this paper
• Deleted in liver cancer 1 suppresses the growth of prostate cancer cells through inhibiting Rho-associated protein kinase pathway

  2022cites this paper
• CDK5 Inhibitor Seliciclib Promotes Osteoblastic Differentiation of MSCs and Suppresses the Migration of MG-63 Osteosarcoma Cells

  2020influential citation
• Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer

  2020cites this paper
• Myosin phosphatase: Unexpected functions of a long-known enzyme.

  2019cites this paper
• Identification of genes related to skeletal muscle growth and development by integrated analysis of transcriptome and proteome in myostatin-edited Meishan pigs.

  2019cites this paper
• DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA

  2019cites this paper
• The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells

  2019cites this paper
• Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model.

  2019cites this paper
• Using pgRNA-Cas 9 System to Knockout MKL 1 Inhibited Cell Migration and Proliferation

  2018cites this paper
• Using pgRNA–Cas9 system to knockout MKL1 inhibited cell migration and proliferation

  2018cites this paper
• Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells

  2017cites this paper
• Investigation of novel functions of myosin phosphatase and smoothelin-like 1 protein

  2017cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Transcription Factors, Signal Pathways Regulating Proliferation and Apoptosis, and Telomeres/Telomerases

  2017cites this paper
• Tensins are versatile regulators of Rho GTPase signalling and cell adhesion

  2017cites this paper
• Maternal BMI as a predictor of methylation of obesity-related genes in saliva samples from preschool-age Hispanic children at-risk for obesity

  2017cites this paper
• BIO015859 452..460

  2016cites this paper
• DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer

  2016influential citation
• Mechanisms of Invasion and Metastasis: Cell Migration and Chemotaxis

  2016cites this paper
• Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation

  2016cites this paper
• Oridonin suppress cell migration via regulation of nonmuscle myosin IIA

  2016cites this paper
• Deleted in Liver Cancer 3 (DLC3) in the regulation of junctional Rho signaling and cell polarity

  2016cites this paper
• Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method

  2016cites this paper
• Molecular Pathogenesis of Hepatocellular Carcinoma

  2016cites this paper
• MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis

  2015cites this paper
• Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives.

  2015cites this paper
• Withaferin A Suppresses Liver Tumor Growth in a Nude Mouse Model by Downregulation of Cell Signaling Pathway Leading to Invasion and Angiogenesis

  2015cites this paper
• The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity

  2015cites this paper
• BIN3 is a novel 8p21 tumor suppressor gene that regulates the attachment checkpoint in epithelial cells

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion

  2014cites this paper
• ROCK1 as a novel prognostic marker in vulvar cancer

  2014cites this paper
• 4-Amino-2-trifluoromethyl-phenyl retinate inhibits the migration of BGC-823 human gastric cancer cells by downregulating the phosphorylation level of MLC II.

  2014cites this paper
• CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth

  2013cites this paper
• GAP-independent functions of DLC1 in metastasis

  2013cites this paper
• EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers

  2013cites this paper
• Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer

  2013cites this paper
• START-GAP/DLC Family Proteins: Molecular Mechanisms for Anti-Tumor Activities

  2013cites this paper
• Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.

  2013cites this paper
• ROCK 1 and ROCK 2 are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion

  2012influential citation
• Therapeutics , Targets , and Chemical Biology ROCK 1 and ROCK 2 Are Required for Non-Small Cell Lung Cancer Anchorage-Independent Growth and Invasion

  2012cites this paper
• ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion.

  2012cites this paper
• Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease

  2012cites this paper
• Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation

  2012cites this paper
• EGF-like factors induce expansion of the cumulus cell-oocyte complexes by activating calpain-mediated cell movement.

  2012cites this paper
• Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis

  2012cites this paper
• Intercellular signalling, cell fate and cell shape in the Drosophila pupal wing

  2012cites this paper
• Genomics of Hepatocellular Carcinoma

  2012cites this paper
• Fibroproliferative Disorders and Their Mechanobiology

  2012cites this paper
• Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton

  2012cites this paper
• MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility.

  2012cites this paper
• Deleted in liver cancer protein family in human malignancies (Review).

  2011cites this paper
• The tumor suppressor protein DLC1 is regulated by PKD-mediated GAP domain phosphorylation.

  2011cites this paper
• DLC1 (deleted in liver cancer 1)

  2011cites this paper
• Pilot Study: Alteration of Deleted in Liver Cancer1 and Phosphorylated Focal Adhesion Kinase Y397 Cytoplasmic Expression and the Prognostic Value in Advanced Epithelial Ovarian Carcinoma

  2011cites this paper
• Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery

  2011cites this paper
• Overexpression of engulfment and cell motility 1 promotes cell invasion and migration of hepatocellular carcinoma.

  2011cites this paper
• MYBPH, a transcriptional target of TTF‐1, inhibits ROCK1, and reduces cell motility and metastasis

  2011cites this paper
• Title Transcriptional repressive H 3 K 9 and H 3 K 27 methylationscontribute to DNMT 1-mediated DNA methylation recovery

  2011cites this paper
• Overexpression of kappa-actin alters growth properties of hepatoma cells and predicts poor postoperative prognosis.

  2011cites this paper
• Early effects of C-Raf ablation in liver regeneration upon a toxic insult

  2010cites this paper
• Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis.

  2010cites this paper
• START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2.

  2010cites this paper
• RhoGTPases and Rho‐effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it

  2010influential citation
• F-Actin Reorganization and Inactivation of Rho Signaling Pathway Involved in the Inhibitory Effect of Coptidis Rhizoma on Hepatoma Cell Migration

  2010cites this paper
• Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling

  2010cites this paper
• Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma

  2010cites this paper
• Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis

  2009cites this paper
• Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.

  2009cites this paper
• The role of the deleted in liver cancer protein family in breast epithelial cell transformation

  2009cites this paper
• DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway

  2009cites this paper
• Rho GTPases in hepatocellular carcinoma.

  2009cites this paper
• Role and significance of focal adhesion proteins in hepatocellular carcinoma

  2009cites this paper